Currently Viewing Posts in rfhzfosf

Senior Tory MPs urge Theresa May to cancel Brexit vote

first_img Senior Tory MPs have urged Prime Minister Theresa May to cancel tomorrow’s vote on her Brexit deal amid fears she faces another heavy defeat, the Times has reported.Leading Conservatives have told May she should pull the meaningful vote unless she secures major concessions from the EU. James Warrington Monday 11 March 2019 7:29 am More From Our Partners Brave 7-Year-old Boy Swims an Hour to Rescue His Dad and Little Sistergoodnewsnetwork.orgA ProPublica investigation has caused outrage in the U.S. this weekvaluewalk.comFlorida woman allegedly crashes children’s birthday party, rapes teennypost.comAstounding Fossil Discovery in California After Man Looks Closelygoodnewsnetwork.orgConnecticut man dies after crashing Harley into live bearnypost.comRussell Wilson, AOC among many voicing support for Naomi Osakacbsnews.comPolice Capture Elusive Tiger Poacher After 20 Years of Pursuing the Huntergoodnewsnetwork.orgBiden received funds from top Russia lobbyist before Nord Stream 2 giveawaynypost.comNative American Tribe Gets Back Sacred Island Taken 160 Years Agogoodnewsnetwork.org980-foot skyscraper sways in China, prompting panic and evacuationsnypost.comMatt Gaetz swindled by ‘malicious actors’ in $155K boat sale boondogglenypost.comInside Ashton Kutcher and Mila Kunis’ not-so-average farmhouse estatenypost.comWhy people are finding dryer sheets in their mailboxesnypost.com‘Neighbor from hell’ faces new charges after scaring off home buyersnypost.comKiller drone ‘hunted down a human target’ without being told tonypost.comKamala Harris keeps list of reporters who don’t ‘understand’ her: reportnypost.comUK teen died on school trip after teachers allegedly refused her pleasnypost.comSupermodel Anne Vyalitsyna claims income drop, pushes for child supportnypost.com by Taboolaby TaboolaSponsored LinksSponsored LinksPromoted LinksPromoted LinksYou May LikeMoneyPailShe Was A Star, Now She Works In ScottsdaleMoneyPailInvestment GuruRemember Cote De Pablo? Take A Deep Breath Before You See Her NowInvestment GuruPost FunRare Photos Show Us Who Meghan Markle Really IsPost FunParenting FactorLily From The AT&T Ads Is Causing A Stir For One ReasonParenting FactorLiver Health1 Bite of This Melts Belly And Arm Fat (Take Before Bed)Liver HealthZen HeraldEllen Got A Little Too Personal With Blake Shelton, So He Said ThisZen HeraldGrowitchRemember Penny From The Big Bang Theory? This Is Her NowGrowitchElite HeraldExperts Discover Girl Born From Two Different SpeciesElite HeraldNational Penny For Seniors7 Discounts Seniors Only Get If They AskNational Penny For Seniors Read more: Brexiters dismiss reports they could swing behind PM’s deal if she resignsInstead, they said the Prime Minister should table a motion outlining the kind of Brexit deal Tory MPs would accept in a bid to maintain party unity and put pressure on Brussels, according to the report.“As it stands her deal is going to be defeated,” a party source told the newspaper. “It has been made clear to Downing Street that it would be eminently sensible to avoid that by proposing a motion that the party can support. Whether they listen or not is another matter.”The comments come amid frantic negotiations in Brussels as negotiators try to reach a last-minute agreement with the EU, largely centred on the issue of the Irish backstop.On Friday the EU’s chief negotiator, Michel Barnier, said the UK will have the option to withdraw unilaterally from the customs union element of the backstop. Senior Tory MPs urge Theresa May to cancel Brexit vote whatsapp Read more: EU offers UK customs union exit amid backstop impasseMay is hoping her revised Brexit deal will be voted through by parliament after her crushing defeat by 230 votes in January.If the vote is rejected, there will be further votes on Wednesday and Thursday that could lead to Brexit being delayed. Tags: Brexit People Theresa May Share whatsapplast_img read more

UK private sector pay is growing at its fastest rate in 15 years – Resolution Foundation

first_imgPay in the private sector is likely to be growing at its fastest pace in 15 years, a think tank has said today. The Resolution Foundation believes workers’ pay packets – once inflation has been taken into account – will have grown between 3.4 and 3.6 per cent in the three months to August when official figures are published this week.  Monday 12 October 2015 12:00 am UK private sector pay is growing at its fastest rate in 15 years – Resolution Foundation whatsapp Chris PapadopoullosChris Papadopoullos was City A.M.’s economics reporter until February 2016. He is an economist at OMFIF. This is likely to be faster than in July 2002 when real pay rose 3.45 per cent and possibly even May 2001 when it grew 3.54 per cent.While low inflation, driven this year by a collapse in the price of oil and commodities, has boosted the figure, the Resolution Foundation also says that the increase in pay is due to job creation shifting toward higher paid roles. Managerial roles have made up a growing sharer of the workforce over the last year, it said. The government talked up the figures. “Today’s report by the Resolution Foundation is further evidence that our economic plan is working  – We have one of the fastest growing advanced economies, there are more people in work than ever before and pay cheques are rising strongly,” a Treasury spokesperson said. However, some were more cautious about the forecast.  by Taboolaby TaboolaSponsored LinksSponsored LinksPromoted LinksPromoted LinksYou May LikeMoneyPailShe Was A Star, Now She Works In ScottsdaleMoneyPailPost FunKate & Meghan Are Very Different Mothers, These Photos Prove ItPost FunSwift VerdictChrissy Metz, 39, Shows Off Massive Weight Loss In Fierce New PhotoSwift VerdictComedyAbandoned Submarines Floating Around the WorldComedyMaternity WeekA Letter From The Devil Written By A Possessed Nun In 1676 Has Been TranslatedMaternity Weekzenherald.comMeghan Markle Changed This Major Detail On Archies Birth Certificatezenherald.comGameday NewsNBA Wife Turns Heads Wherever She GoesGameday NewsBridesBlushThis Is Why The Royal Family Kept Quiet About Prince Harry’s Sister BridesBlushEquity MirrorThey Drained Niagara Falls — They Weren’t Prepared For This Sickening DiscoveryEquity Mirror “While the immediate outlook for pay is healthy, it will be far harder to maintain this ‘catch-up’ growth once inflation starts to return, especially with the labour market still under-performing in many key areas,” said Laura Gardiner, a policy analyst at the Resolution Foundation. “The relatively subdued level of moving between jobs among young people is a particular cause for concern, as it can harm career prospects and their long-term earnings potential.The Foundation also said there would need to be a substantial lift in pay growth once inflation begins to rise in order to keep up the pace. Inflation was zero per cent in August and the Bank of England is predicting it will hit one per cent sometime next spring. “After a long wait, it’s good news that many workers are finally seeing real pay improvements,” said Frances O’Grady, general secretary of the Trades Union Congress. “However, earnings remain some way off their pre-crash position, too many self-employed workers are stuck at the bottom, and there is no public sector pay recovery.” Share whatsapp Show Comments ▼ More From Our Partners Native American Tribe Gets Back Sacred Island Taken 160 Years Agogoodnewsnetwork.orgRussell Wilson, AOC among many voicing support for Naomi Osakacbsnews.comPolice Capture Elusive Tiger Poacher After 20 Years of Pursuing the Huntergoodnewsnetwork.orgMan on bail for murder arrested after pet tiger escapes Houston homethegrio.comBrave 7-Year-old Boy Swims an Hour to Rescue His Dad and Little Sistergoodnewsnetwork.orgKansas coach fired for using N-word toward Black playerthegrio.comAstounding Fossil Discovery in California After Man Looks Closelygoodnewsnetwork.orgLA news reporter doesn’t seem to recognize actor Mark Currythegrio.comFans call out hypocrisy as Tebow returns to NFL while Kaepernick is still outthegrio.comlast_img read more

News / Rival carriers gaining on Maersk in the box ship capacity stakes

first_img Maersk’s share of global container shipping capacity has shrunk by 1.5% in the past 12 months, while its main rivals, particularly Cosco, have gained ground on the market leader, according to Alphaliner’s latest data.The capacity offered by Maersk Line and its subsidiaries has declined by 2.6% to 4.02m teu while global capacity increased by 6% to 22.69m teu during the same period, noted the consultant.“Maersk is expected to continue to retreat in the next 12 months, as its CEO, Soren Skou, has confirmed that it will not pursue further acquisitions or order large new ships in 2019,” said Alphaliner.“Maersk could face a further challenge in December, when the forced withdrawal from its Far East-east coast South America partnerships will trigger a major shake-up on that trade.”Alphaliner said the withdrawal, demanded by Chinese regulators as a condition of Maersk’s takeover of Hamburg Süd, would prove a further challenge, as rivals circled to pick off its customers.Nevertheless, according to Maersk Line’s chief commercial officer, Vincent Clerc, Hamburg Süd shippers are proving loyal. Last week, Mr Clerc claimed volumes had so far been retained, although annual contract renewals were still to come.“The Hamburg Süd team has done a fantastic job in retaining their business during the integration of the networks in the second quarter, and we can see that their customers are still with them, and the volumes keep on coming as we expected them to,” he said during Maersk’s Q3 earnings call.He attributed the high retention to its takeover “trade-off” in keeping the separate Hamburg Süd “brand, organisation and value proposition”.During the same earnings call Mr Skou confirmed the carrier was “not planning to order any large ships before 2020 at the earliest”.And chief operating officer Soren Toft confirmed the carrier’s capacity retrenchment strategy: “We expect to continue to reduce capacity slightly going into the fourth quarter, so we land around the 4m teu mark, and we expect that capacity will remain stable, plus or minus a little bit when we look into 2019.”Following the restructuring of its business, Maersk no longer publishes the net profit or loss for its individual transport and logistics sectors, but based on Alphaliner estimates, the carrier’s ebit margin declined to 3.8% in the third quarter, versus the 4.1% margin in its Q3 17 accounts.According to Alphaliner’s capacity league table, the biggest capacity gain during the 12-month period was by Cosco, 11.6% to 12.4% from a number of big ship deliveries, while Evergreen, Hapag-Lloyd, Yang Ming and HMM all added capacity, but surprisingly, not CMA CGM.Of particular note is that the table reveals that MSC conceded 0.1% in capacity share, year on year, which could be of concern to the normally bullish Geneva-headquartered carrier. MSC’s capacity growth aspirations are clearly being held back by the cautious network approach of its 2M alliance partner, Maersk. By Mike Wackett 21/11/2018 © Vladimir Serebryanskiylast_img read more

FDA advisory panel endorses Johnson & Johnson Covid-19 vaccine

first_img About the Authors Reprints HealthFDA advisory panel endorses Johnson & Johnson Covid-19 vaccine MARK RALSTON/AFP via Getty Images Matthew Herper Tags CoronavirusVaccines By Helen Branswell and Matthew Herper Feb. 26, 2021 Reprints The J&J vaccine was found to reduce cases of moderate to severe Covid infection by 66.1%, starting 28 days after the single shot. (It takes a while for the protection of the vaccine to build up.) Results released in late January suggested the vaccine worked better in some areas than others; in the U.S., the vaccine was 72% protective.An FDA analysis of the J&J data, released on Wednesday, suggested the vaccine was a little less effective against a virus variant first spotted in South Africa, known as B.1.351. But its protection did not appear to be eroded by a variant first spotted in Brazil, known as P.2.The United States has purchased 100 million doses of the J&J vaccine, but supplies are expected to be scarce until at least April.STAT’s coverage of the meeting is below, with updates and analysis posted in reverse chronological order.What the vote means, according to the panelists6:05 p.m.: The committee evaluating J&J’s vaccine voted 22-0 that its benefits outweigh its risks. That compares to a 17-4 vote for the first authorized Covid-19 vaccine, made by Pfizer and BioNTech, and a 21-0 vote, with one abstention, for Moderna’s vaccine. That doesn’t mean, however, that this vaccine is the best one, according to public comments made by panelists themselves after they voted. Rather, several said the vote represents an increased confidence on their part in the FDA’s emergency use authorization process, and a feeling that the system is working thanks to the success of those earlier vaccines.Patrick Moore of the University of Pittsburgh noted that when the Pfizer/BioNTech vaccine was the first to go through the EUA process, there were data from 45,000 volunteers, about the same amount now available for the J&J vaccine. But 55 million people have now received one of the two available vaccines, he said, and “things are looking good.” He added: “This process does seem to have worked despite my concerns about it six months ago.” Moore said he wanted the public to know that experts are thinking hard about these decisions during the health emergency. Arnold Monto, a University of Michigan professor and chair of the panel, agreed.“The increased confidence in the process should be measured by the changing votes that we’ve had in subsequent reviews,” Monto said.  “We’re very comfortable with the procedure as well as the vaccines we are approving.”— Matthew HerperThe vote5:05 p.m.: The panel voted on only a single question: Based on the totality of scientific evidence available, do the benefits of the Janssen Covid-19 vaccine outweigh its risks for individuals 18 years of age and older?The results were unanimous — all 22 panelists voted yes. Now, there will be a discussion on why the panelists voted the way they did, which could be as important as the vote in determining how the vaccine is authorized.— Matthew HerperThe elephant in the room didn’t garner much discussion4:50 p.m.: J&J’s data on the one-dose vaccine’s effectiveness in older adults aren’t spectacular; they really didn’t have that much, especially for adults 75 and older. It doesn’t mean the vaccine doesn’t work in older adults; it may. But the trial didn’t prove it. In the FDA’s analysis of the J&J data, posted online earlier this week, the agency said the data in people 75 and older had “limited interpretability” because of small numbers.Their analysts didn’t even try to calculate a vaccine efficacy ratio for people in that age for the period of 28 days and later after vaccination. And some of J&J’s data raises questions about how well the vaccine works in adults 60 and older who have comorbidities, or underlying medical conditions. (Comorbidities are not rare in adults over the age of 60.) Looking at adults 60 and older with comorbidities from 28 days after vaccination, the vaccine efficacy estimate was 42%, but that lower figure could just due to chance given the smaller number of Covid cases in that group.Yet there were surprisingly few questions about the lack of evidence for the vaccine’s efficacy in older adults. Even FDA’s Peter Marks, director of the Center for Biologics Evaluation and Review, seemed taken aback — he jumped into the discussion at a point to ask committee members to give FDA some indication of how comfortable they were about the evidence to support use of the vaccine in the older adults and the elderly.“It would be good to hear some comments about that,” Marks noted. He didn’t get much in reply.Panelist Mark Sawyer, a professor of pediatrics at the University of California San Diego, asked if J&J could peek at data being generated in its ongoing trial testing two doses. (Not currently, the company said. The trial is double blinded.) Panelist Melinda Wharton, director of CDC’s immunization services division, asked if there had been additional data generated by the one-dose study that could shed more light on the question. (Yes, said the company. But it is also still blinded.)And that was that.— Helen BranswellOne dose or two doses, Part 24:35 p.m.: To understand what’s coming next, you need to know that J&J has been conducting two clinical trials in the United States, a 44,000-person trial testing one dose, and a 30,000-person trial testing two doses. The amount of antigen used in the one-dose trial is higher than the amount used in the individual doses in the two-dose trial.Ofer Levy, a Harvard University vaccinologist, asked Janssen’s Johan Van Hoof whether the company considered testing an intermediate dose, or testing whether an adjuvant — a compound that boosts the response to a vaccine — could improve the vaccine’s effectiveness.Van Hoof said the company is actually studying whether giving “a very late boost” with “a small amount of antigen” to people who got the one-dose regimen would heighten the protection they get from the vaccine. He didn’t provide any details on how late late is, or how small small is. The work is ongoing, Van Hoof said.— Helen BranswellIs this really a one-dose vaccine? Or a two-dose vaccine?4:10 p.m.: As Matt noted earlier, there are questions being raised about whether the J&J vaccine is a one-dose vaccine or whether a 30,000-person trial still under way is going to show the vaccine really should be given in two doses. That trial isn’t expected to report until some time in May.Marion Gruber, FDA’s director of the Office of Vaccines Research and Review, jumped into the discussion a few minutes ago, possibly to avert problems later on in the voting.Gruber noted that the application before the FDA at this point is for an emergency use authorization of a one-dose vaccine. If data that come in down the road suggest two doses of this vaccine are needed or at least better, that issue could be addressed when J&J applies for full licensure of the vaccine.— Helen BranswellWill being vaccinated make people less sick if they get Covid?3:50 p.m.: James Hildreth, a panelist and the CEO of Meharry Medical College, asked if there was any evidence that people who develop Covid after receiving the vaccine experience milder illness than those who developed Covid in the placebo group.Johan Van Hoof, from J&J, referred him to page 65 of the company’s briefing document. According to that document, the score on a questionnaire about symptoms was reduced 24% on day one for those who received vaccine compared to those in the placebo group on day one of the infection, and by 55% on day 14. Those who received the vaccine reported four to six symptoms, while those in the placebo group reported seven to nine symptoms. Those last two numbers are from a post-hoc, or after-the-fact, analysis, which makes them less reliable. Still, Hildreth said, this is an important thing to communicate to the public.— Matthew HerperAnalysis of adverse events3:30 p.m.: The FDA’s analysis of side effects from vaccination focused on clotting disorders, tinnitus (buzzing or ringing in the ears), and urticaria, better known as hives.For all three conditions, the agency’s scientists concluded there might be a link between receipt of the vaccine and the side effects, though the numbers were very small. For two — the clotting conditions and tinnitus — they said vaccine could not be ruled out as a possible contributing cause; for urticaria, they said there was a plausible relationship to vaccination.When you read these numbers, keep in mind that this was a study involving 44,000 people.There were six cases of tinnitus among people who got vaccine versus none in the placebo arm of the trial. Half of the tinnitus cases occurred within two days of vaccination, the other three began within 12 to 22 days of vaccination.Among the clotting events, there were six cases of deep vein thrombosis in the vaccine arm, compared to two in the placebo arm. There were four pulmonary embolisms — clots in the lungs — in vaccine recipients, compared to one in a person in the placebo arm. And there was one case of sinus venous thrombosis, a blood clot in the brain’s venous sinuses, in a vaccine recipient.With both the clotting events and the tinnitus, the FDA said the people involved had other health problems that made it difficult to determine whether receipt of the vaccine might have played a role.There were eight cases of hives among vaccine recipients, compared to three among placebo recipients.The FDA also concluded three serious adverse events were likely linked to receipt of the vaccine. A 42-year-old man had a hypersensitivity event — he developed a widespread rash and his lips swelled within a few days of vaccination, and a 30-year-old man had injection site pain that spread to include more of his arm. Finally, a 35-year-old man developed extreme generalized weakness, fever, and a headache on day 2 post injection and was hospitalized but recovered.— Helen BranswellCommunicating with the public about vaccines is about get more difficult2:55 p.m.: One thing that’s been clear from the panel discussion about J&J’s vaccine: The job of communicating with the public about Covid-19 vaccines, already a minefield, is about to get more treacherous.During late morning discussion, Paul Offit, a panelist and a well-known vaccine researcher at Children’s Hospital of Philadelphia, asked how J&J plans to shift its communication if, in the end, this ends up being a two-dose vaccine. In its first trial, the company tested a single dose. But a second, 30,000-patient trial aims to test a two-dose regimen.Offit’s question: What if the two-dose regimen works better? How do we explain that to the public?Questions like that are going to be more fraught, and Offit, who has written at length about the way discussion about the vaccine preservative thimerasol backfired and led to unwarranted vaccine skepticism, is well aware of it.In the open public hearing, Diana Zuckerman of the National Center for Health Policy Research made a different point. Many public health experts are emphasizing that the vaccines prevent severe Covid or death. But the number of severe cases is small, and the number of deaths is even smaller. It’s misleading, she said,  to tell the public that nobody who got the vaccine was hospitalized unless you also tell them that only five people were hospitalized.Nabarun Dasgupta, a senior scientist at the University of North Carolina, made a plea for apps being used to track side effects to offer more to users, lest those people don’t participate in research. But he made another complicated point. Right now, people don’t get a choice of which vaccine they are going to receive. But for groups that are vaccine hesitant, he argued, the ability to choose which vaccine they receive could make them more willing to get vaccinated, because it will give them a sense of agency.Nobody said it would be easy.—Matthew HerperAnaphylaxis again rears its head12:35 p.m.: Cases of anaphylaxis have been reported after receipt of both the Pfizer and the Moderna vaccines. There had been no reports of this severe, life-threatening allergic reaction in people who have received the J&J vaccine. Up until now.Macaya Douoguih, head of clinical development and medical affairs for Janssen, J&J’s vaccines division, told the panel that on Wednesday, the company was informed that someone who was taking part in an open-label study in South Africa developed anaphylaxis after receiving the vaccine. (In an open-label study, both participants and researchers know whether a participant is getting vaccine or a placebo.)Anaphylaxis requires rapid administration of epinephrine to combat the closure of airways that the reaction triggers. The CDC requires people administering Covid vaccines to monitor people for 15 minutes after vaccination, and 30 minutes for people in whom the risk of anaphylaxis after vaccination is high.The CDC has been monitoring anaphylaxis events in the vaccine rollout. In a presentation earlier today CDC’s Tom Shimabukuro reported that to date it is seen at a rate of about 4.7 cases per one million doses of the Pfizer vaccine and 2.5 cases per one million doses of the Moderna vaccine.— Helen BranswellHow J&J’s vaccine works12:20 p.m.: Hanneke Schuitemaker, J&J’s global head of viral vaccine discovery, presented a discussion of how the J&J vaccine works and how it was developed.The vaccine is a modified cold virus, known as an adenovirus. The modified virus, known as a vector, is called Ad.26. One gene was deleted to make Ad.26 unable to replicate in humans. A second gene was deleted to make room for a synthetic gene, called a transgene, that is added to the virus. The FDA classifies the vector as non-integrating, J&J said, meaning that this won’t change the DNA of the volunteer’s cells.Instead, the virus infects cells in the vaccine recipient and makes lots of copies of a protein coded by this transgene, which the immune system then learns to recognize and attack. In this case, as with other Covid-19 vaccines, this is a copy of the spike protein, which SARS-CoV-2 uses to enter human cells. J&J tried multiple versions of this spike protein to create a vaccine with what Schuitemaker called “optimal stabilization, expression, immunogenicity, efficacy.”The vaccine prevented non-human primates from being infected through their lungs, and almost eliminated SARS-CoV-2 virus in their noses.A single dose of the vaccine also clearly reduces cases in humans. Macaya Douoguih, another J&J scientist, presented data from J&J’s clinical trials which showed the vaccine reduced the risk of severe disease. Still, the numbers are small. There appear to have been 6 deaths from Covid-19 observed in the study, none of them in patients who received the vaccine. All of them were in South Africa, where the B.1.351 strain has become prevalent.—Matthew HerperJ&J plans for studying its vaccine in special populations11:40 a.m.: Johan Van Hoof, managing director of Janssen Vaccines, J&J’s vaccine division, told the panel that a trial to study the safety and efficacy of the company’s vaccine in pregnant people will begin in late March or early April. It plans to study the vaccine in children under the age of 17, with a trial in adolescents to start soon.The company also plans to study the safety and efficacy of the vaccine in people who are immunocompromised in the third quarter of this year.— Helen BranswellSo far so good on data during pregnancy11:15 a.m.: There was good news for pregnant people reported in a presentation on the safety data that are emerging from use of Covid vaccines.Tom Shimabukuro from the Centers for Disease Control and Prevention reported on the monitoring of people who received a Covid vaccine while pregnant. The safety of the vaccines hasn’t yet been proven in this population because pregnant people were excluded from the clinical trials. Pfizer announced earlier this month it had started a Phase 2/3 trial to determine whether its vaccine is safe and effective in this important population group.Shimabukuro said to date there have been 154 adverse events reported by pregnant people in the Vaccine Adverse Event Reporting System, which is operated by the CDC and the FDA. About half of those people report having been vaccinated in the first 13 weeks of their pregnancies.Most of the adverse events reported were not related to pregnancy — things like headache, fatigue, chills, and reactions at the injection site, Shimabukuro said. There were 29 spontaneous abortions or miscarriages reported, but about 10% to 20% of all pregnancies end through spontaneous abortions or miscarriages, he noted.“The number was not concerning considering the expected background rate,” Shimabukuro said.The CDC, through its V-safe vaccine safety surveillance system, is maintaining a registry of people who report they were pregnant following vaccination. They are being followed, with check-ins every three months and another three months after the birth of the baby. There are 1,815 people in the pregnancy registry so far.Overall, Shimabukuro’s update suggested no concerning safety signals have emerged so far related to the Covid vaccines currently in use in the United States. “Anaphylaxis does occur, though rarely, and there are no safety signals for any serious adverse events,” he told the panel.— Helen BranswellNew data drive home the threat from coronavirus variants10:30 a.m.: Adam MacNeil, an epidemiologist at the Centers for Disease Control and Prevention, showed the panel new data on the three SARS-CoV-2 variants researchers have been most worried about: B.1.1,7, B.135.1, and P.1. The grim message: Variant strains of the virus are dangerous and widespread.All three of those variants have been detected in the U.S.  “We have to assume in the absence of other information that these variants probably could exist throughout the entire U.S.,” he said.The B.1.1.7 variant has become the predominant strain in the U.K. and in much of Europe. MacNeil presented conclusions from unpublished data reviewed by the New and Emerging Viruses Threats Advisory Group that deaths and hospitalizations were 1.7 times higher with the new variant, which are thought to have arrived in the U.S. in November. In models, a scaling up of vaccination could blunt the increase in cases from the variant.B.135.1 is worrisome because it has shown the potential to reinfect previously infected or vaccinated people in some cases. (This means that the vaccines would become less effective, but would still protect against Covid-19.) MacNeil showed data from Zambia in which the B.135.1 variant, previously undetected, drove a 16-fold increase in cases in one month.P.1. also seems to be able to overcome immunity. He described the experience in Manaus, Brazil, where an epidemic resulted in 76% of people having been infected. The emergence of P.1 resulted in a new spike in hospitalizations there, despite this apparent herd immunity.MacNeil also said that right now, the U.S. is “nowhere close” to having herd immunity. The U.S. surveillance effort is scaling up, but it is still not at the scale needed to quickly identify new variants. He also emphasized that current strategies, like masking and social distancing, work and that vaccines, even with decreased effectiveness, vaccinations could still provide partial protection.—Matthew HerperHo-hum?9:35 a.m.: Has the excitement gone out of the prospects of emergency use authorizations for new Covid-19 vaccines? I ask because there are about 1,900 people watching the J&J hearing right now.During the first VRBPAC hearing for a Covid vaccine, the Dec. 10 meeting on Pfizer and BioNTech’s vaccine, there were more than 15,000 people watching at points in the day.— Helen BranswellThe path forward8:10 a.m.: It seems a sure bet the VRBPAC will recommend that the FDA authorizes the J&J vaccine, and that FDA will do it quickly — as early as Saturday, perhaps.Why do we think so? For one thing, the agency moved rapidly to issue EUAs for the Pfizer and Moderna vaccines. For another, the expert panel that issues recommendations to the Centers for Disease Control and Prevention on how vaccines should be used is meeting in an emergency session on Sunday to discuss the J&J vaccine. That group, the Advisory Committee on Immunization Practices, or ACIP, makes recommendations only after the FDA authorizes use of a vaccine. So, its Sunday meeting is a pretty solid clue.If the FDA authorizes the J&J vaccine on Saturday and ACIP issues recommendations on Sunday, supplies of the vaccine could start to ship almost immediately. But J&J doesn’t have a ton of vaccine to plug into the pipeline at this point. We’re hearing amounts in the very low single digit millions of doses until April.The vaccine will be entering the distribution program at a time when 46 million Americans have had a least one dose of vaccine and 21.5 million have received two doses — 8.4% of the population over 18 years of age.It also comes at a time when new cases are declining and shortly after the country hit an ignominious mark — the U.S. death toll from Covid topped 500,000 people.— Helen BranswellVRBPAC’s agenda7 a.m.: Good morning, STAT readers.Your VRBPAC live-bloggers today are Matthew Herper and me, Helen Branswell.For starters, let’s introduce you to the committee members. The FDA has a very strict conflict of interest policy for VRBPAC members. Anyone involved in any of the Covid-19 clinical trials — even a member who works at a university that is a trial site — is “conflicted out,” which means that temporary replacements who are equally stringently vetted are named to sit in their place. Most of the members of today’s panel sat when VRBPAC evaluated the earlier two Covid vaccines.The early part of the meeting, which begins at 9 a.m. EST, is mostly housekeeping. There’s a presentation on what emergency use authorizations are, and one on what surveillance data are indicating about the safety of the two Covid vaccines currently in use. There is also a session on the various virus variants — say that three times fast! — that are circulating and raising concerns about vaccine efficacy.At 11:10 a.m. EST, a team from J&J will present their take on the data on their vaccine and will be questioned on it by committee members. After lunch — if there is a lunch break, VRBPAC meeting sessions often run long — FDA scientists will present their review of the data. And then VRBPAC members will be asked one or several questions by the FDA and will take one or several votes.The meeting is meant to conclude at 5:30 pm. EST. We’ll see.— Helen BranswellCorrection: An earlier version of this story misstated the number of Americans who have received at least one dose of Covid vaccine. Senior Writer, Medicine, Editorial Director of Events Matthew covers medical innovation — both its promise and its perils. @HelenBranswell Helen Branswell @matthewherper An advisory panel on Friday recommended the Food and Drug Administration grant an emergency use authorization for Johnson & Johnson’s Covid-19 vaccine developed by Johnson & Johnson, which would become the third vaccine authorized in the United States and the first to require a single shot.In a statement issued shortly after the vote, the FDA said it has told the company regulators “will rapidly work toward finalization and issuance of an emergency use authorization.” The agency also said it has notified federal partners involved in vaccine distribution “so they can execute their plans for timely vaccine distribution.”Authorization of J&J’s vaccine could be a potential game changer, at least in some areas. Made by J&J’s vaccine division, Janssen Pharmaceuticals, the single-dose vaccine does not need to be frozen when it is shipped and distributed. The vaccine is what’s known as “fridge stable,” meaning it can be shipped and stored at the temperature of a regular refrigerator. Both those characteristics will make this vaccine much easier to deploy if the FDA authorizes its use. The two vaccines already in use in the United States, from Moderna and the Pfizer-BioNTech partnership, are both two-dose vaccines with onerous cold-chain requirements.advertisement [email protected] FDA scientists endorse J&J’s Covid vaccine, as new data shed light on efficacy Although the FDA does not have to follow the recommendation of the panel, known as the Vaccines and Related Biological Products Advisory Committee or VRBPAC, it is widely expected to do so.The J&J vaccine hasn’t been tested yet in children and teens under the age of 18, so it will not be authorized for use in them.advertisement Senior Writer, Infectious Disease Helen covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Related:last_img read more

Third defeat on the spin for Portlaoise Panthers Men

first_img WhatsApp Twitter Pinterest New Arles road opens but disquiet over who was invited to official opening TAGSBasketballMens National LeaguePortlaoise Panthers Portlaoise Panthers 77 Scott’s Lakers St Paul’s Killarney 94Mens Division 1 National League BasketballPortlaoise Panthers welcomed Scott’s Lakers St Paul’s Killarney to St Mary’s hall this evening where Panthers lost out by 17 points.The loss means that Panthers have suffered 3 losses in a row in their National League campaign having been defeated by IT Carlow and Fr Mathews last weekend. Facebook RELATED ARTICLESMORE FROM AUTHOR Third defeat on the spin for Portlaoise Panthers Men Twitter Five Laois monuments to receive almost €200,000 in government funding Pinterest Community Charlie Flanagan on Electric Picnic: ‘I’d ask organisers to consult with community leaders’ By Aedín Dunne – 29th September 2018 Previous articleYoungsters to the fore as courageous Courtwood defeat the Gaels to claim IFC titleNext articleDeaths in Laois – Sunday, September 30, 2018 Aedín DunneAedín graduated from University of Limerick with a degree in Journalism and New Media. She is a proud Townie with a passion for all things sports and doesn’t like to speak about the 2016 blip in Portlaoise’s bid to 10-in-a-row. Home Sport Basketball Third defeat on the spin for Portlaoise Panthers Men SportBasketball Community Facebook WhatsApp Mike Pierre and Sean Condon sank 2 scores but it was Pierre and Vilimas who kept Panthers; within touching distance of the visitors heading for half time scoring 10 between them in the last few minutes of the quarter, to leave their side trailing by 5.The game began to change in the third quarter and Killarney began to pull away. In the first 5 minutes, the away side pulled ahead by 8 points. Within another 3 minutes, Panthers saw themselves 14 points down despite scores from Trevor Swayne, James Phelan and Mike Pierre.A super opening to the final quarter came from an assist from Jack Dooley followed by Trevor Swayne’s shot just missing the basket and Pierre rebounding and claiming the score. Mantis Vilimas scored the next two baskets just before captain Jack Dooley was disqualified from the game following a technical foul.A compilation of scores from Pierre, Vilimas, Sean Condon and Dylan Dunne were not enough to catch up to the visitors leaving the gap at 17 points at the final buzzer.TOP SCORERS – Mike Pierre; 28, Mantis Vilimas; 14, Sean Condon; 6PORTLAOISE PANTHERS: Jack Dooley, Sean Condon, Gary Morrisey, James Gormely, Kyle Burke, Mike Pierre, James Phelan, Trevor Swayne, Liam Kinsella, Connor Byrne, Edwinas Roscenkovas, Pierce Bloger-Hinds, Shane Buggie, Dylan Dunne, Rian O’ConnellSCOTT’S LAKERS KILLARNEY: Dylan O’Sullivan, Dailian Mason, Mark Greene, Sean O’Brien, Justin Tuason, Andrew Fitzgerald, Marko Bencic, James Murphy, Papito Hersisio, Shane McCarthySEE ALSO – Youngsters to the fore as courageous Courtwood defeat the Gaels to claim IFC title Council Having played well last weekend, all eyes were on Mantis Vilimas and the US’s Mike Pierre where big performances were needed to get Portlaoise back to winning ways.The game began with a few missed chances from Panthers which lead to the first basket of the game coming from Killarney’s Dilian Mason. Mike Pierre responded with a basket as a result of a fast break from Vilimas.Killarney pulled ahead after 5 minutes but baskets a turnover from Kyle Burke ended in him getting the second basket for Portlaoise closely followed by a James Gormley score. Gary Morrisey drew the game with a 3 pointer and Pierre followed suit with another 3 points.The quarter ended with Portlaoise trailing by 2 after 5 points came form Jack Dooley and a 2 pointer from Pierre with 3 seconds to spare.The second quarter looked promising as Panthers only took 20 seconds to claim their first basket of the quarter from Trevor Swayne . As time went on, missed chances from Portlaoise ended in Scott’s Lakers’ scoring a few baskets with super scores and assists coming from the away sides Papito Hersisio.last_img read more

Deaths in Laois – Friday, July 17, 2020

first_img WhatsApp Twitter Laois Councillor ‘amazed’ at Electric Picnic decision to apply for later date for 2021 festival Bizarre situation as Ben Brennan breaks up Fianna Fáil-Fine Gael arrangement to take Graiguecullen-Portarlington vice-chair role Twitter Pinterest Pinterest Electric Picnic By LaoisToday Reporter – 17th July 2020 Below are the recent deaths in Laois.Ar Dheis De go raibh a anam.Philip MocklerJohnstown Road, Rathdowney, LaoisPhilip (Phil) Mockler, Johnstown Road, Rathdowney, Co. Laois. July 13th 2020. Peacefully in the wonderful care of the nurses and staff of Abbeyleix District Hospital. Predeceased by his son Stephen and daughter Susan. Sadly missed by his wife Gwen and his family Frances, Julie, Philip and Tracey, sons-in-law Jeremy and Fred, daughters-in-law Tracey and Bernie, grandchildren, Tommy, Charley, John, Lewis, Henry, Haley, John-Jo, Lucas, Jade, Joe and Paige, Great-grandchildren, Freddy, Ellie, Sadie, Charley, Tilly, Carter, Ivy, Poppy, Harper, Tommy, Ralph, Harry, Noah, Gracie, Florence and Dominic, his sisters Eileen and Tess, brothers Mick and Jim, nephews, nieces, neighbours, relatives and friends.A private family funeral will take place on Friday, July 24th, at 11am in The Church of The Holy Trinity, Rathdowney. (parishwebsites.ie/rathdowney) followed by burial in Rathdowney Local Cemetery. Please note as per the COVID-19 directive that only fifty people can enter the Church. Social distancing and public health advice must be adheared to.Nicholas (Nicky) BrennanShanganabeg, Barrowhouse, Athy, Kildare, R14 D540/LaoisPeacefully, at the Mater Private Hospital, after a long illness bravely borne. Sadly missed by his loving wife Margaret, son James, daughters Deirdre, Elaine and Nicola, brother Michael, sisters Eithne and Marie, son-in-law Jimmy, brothers-in-law, sisters-in-law, granddaughters Ria and Pippa, nieces, nephews, relatives and friends.Removal from his residence at 1.30pm on Saturday afternoon to arrive at St. Mary’s Church, Barrowhouse for private Requiem Mass at 2pm. Burial afterwards in the adjoining cemetery. Those who would have liked to attend the funeral but cannot due to current restrictions may leave a personal message in the section marked ‘Condolences’ below.Goretti PhelanAvondale, Portarlington, Offaly/Portarlington, LaoisPeacefully at home surrounded by her loving family. Loving daughter of the late Rody and dear partner of the late Kevin Maher. Sadly missed by her loving daughters Siobhan, Louise and Shelly and their father Pat, mother Maureen, brothers Roger, Michael and Adrian, sisters Louise, Caroline, Angela, Orla and Josie, grandchildren Kathlyn, Zoe, Aoibhe, Brook, Seán, Harley and Patrick, son-in-law Danny, Shelly’s partner Tom, aunts, uncles, nieces, nephews, extended family and friends.Removal on Saturday arriving St Michael’s Church Portarlington for Requiem Mass at 11am. Funeral afterwards to St Michael’s Cemetery Portarlington.Due to the Covid 19 Directive Social Distancing will be in place at her residence, in the Church and at the Cemetery.You can leave your Condolences on the Online Condolence Book belowThe family would like to thank you for your help and understanding at this sad and difficult time.Goretti’s Funeral Mass will be streamed live onhttps://www.mcnmedia.tv/camera/st-michaels-church-portarlingtonGeorge T HipwellRathangan, Kildare/Emo, LaoisGeorge T Hipwell, “Kara-Hem”, Tullylost, Rathangan, Co. Kildare, 16th July 2020 at home suddenly and peacefully.He will be sadly missed by his loving family, his wife Mary, sons and daughters, Paul, Eoin, Aine, Olive, brothers and sisters, Denis, Carol, JJ, Desmond, Liam and Pearl, brothers-in-law, sisters-in-law, sons-in-law, daughters-in-law, granchildren, relatives, neighbours and many dear friends, and his colleagues in Coillte.Reposing at his home from 5 p.m. to 7 p.m. Friday(17th July) with rosary at 7 o’clock. In the current circumstances we are requesting those attending his home, please wear a mask and obsersve social distancing guidlines.George’s funeral mass will take place at 11 a.m. Saturday (18th July) in the Church of Assumption and St. Patrick, Rathangan. Burial afterwards in St. Patrick’s Cemetery, Rathangan.Funeral Mass will be live streamed on Saturday morning on the Rathangan Parish facebook page and the iCatholic youtube channel. https://www.youtube.com/c/icatholicplayerMary Moloney (née O’Rourke)Kimmage, Dublin/Portlaoise, LaoisPeacefully while in the tender care of the wonderful staff in Maynooth Community Care Centre. Predeceased by her husband Michael. Sadly missed by her loving family, Philip, Anne, Rosemarie, Michael and Aisling, grandchildren Barry, Owen, Roisín, Gráinne, Ciara, Aedán, Ciaran, Eoghan, Sinéad, Darragh, Ruairí and Caoimhe, sons-in-law, daughter-in-law, great grandchildren, sisters-in-law, nieces, nephews, extended family, neighbours and many friends.Due to current Government restrictions a private Family Funeral will take place in the Church of the Holy Spirt, Kimmage Manor on Saturday, July 18th, at 10am followed by burial at Mount Venus Cemetery. Family flowers only please. Donations if desired to Dublin Simon Community. www.dubsimon.ie.Josie Dayton (née Condren)Boleybeg, Spink, Abbeyleix, Laois/Maganey, LaoisDayton (Josie) Nee Condren Boleybeg, Spink, Abbeyleix & formerly of Grange, Maganey, Co. Laois. At Naas General Hospital. Pre-deceased by her husband James and brother John. Josie will be sadly missed by her brothers Brian and William, sisters-in-law, nieces, nephew, relatives and friends.Reposing at Coady’s Funeral Home, Castlecomer, Co. Kilkenny on Thursday (16th July) from 6pm to 8pm (for close family and friends). Funeral arriving at St. Lazerian’s Church, Knock on Friday morning for Requiem Mass at 11am, with burial in the adjoining cemetery. (Maximum of 50 people allowed in the Church and social distancing adhered to in the cemetery).James (Jim) FitzpatrickKnockbawn Spink, Abbeyleix, LaoisJim died in the loving care of Droimnin Nursing Home, Stradbally. Deeply regretted by his loving wife Teresa, sons John and James, daughter Carmel, brother-in-law, sister-in-law, son-in-law, daughters-in-law, nieces, nephews, grandchildren, relatives, neighbours and friends.Removal from his residence on Friday at 1.30 to St. Lazarian’s Church, Knock for Funeral Mass at 2 pm. Burial afterwards in the adjoining Cemetery. Due to Covid 19 Directive Social distancing will apply at the Church and Cemetery. The family would like to thank you for your help and understanding at this time.Kathleen Henderson (née Costigan)Coolkerry, Rathdowney, LaoisKathleen Henderson (nee Costigan), Coolkerry, Rathdowney, Co. Laois. July 15th 2020. In the wonderful care of the nurses and staff of Brookhaven Nursing Home, Ballyragget, Co. Kilkenny. Predeceased by her husband Pat and her son Pat and her brother John. Sadly mourned by her family Philip, Michael, John, Andrew, daughters in law Ann, Breda, Martina, Agnes, grandchildren John-Paul, Gillian, Brian, Catherine, Ann-Marie, Daniel, Adam, Darragh, Aisling and Patrick, great-grandchildren Lorcan and Liam, nephews, nieces, neighbours, relatives and friends.Reposing at O’Sullivan’s Funeral Home, Rathdowney on Thursday from 7pm to 9pm. Funeral mass on Friday at 11 o’clock in the Church of The Holy Trinity, Rathdowney followed by burial in Rathdowney local cemetery.Please adhere to the COVID-19 Directive with regard to social distancing at public gatherings. Funeral mass will be live streamed from The Church of The Holy Trinity, Rathdowney on Friday at 11o’clock (parishwebsites/rathdowney).Frances (Mary) Cullen (née Bolton)33 St Michael’s Park, Portarlington, LaoisPeacefully at home surrounded by her loving family. Predeceased by her loving husband Paddy. Sadly missed by her children John, Rose, Margaret, Paddy, Mary, Michael and Bernadette, sisters Una and Peg, grandchildren, great-grandchildren, sons-in-law, daughters-in-law, sister-in-law, nieces, nephews, extended family, neighbours and friends.Removal on Thursday arriving St Michael’s Church, Portarlington for Requiem Mass at 12 noon. Funeral afterwards to St Michael’s Cemetery, Portarlington.Due to the Covid 19 Directive Social Distancing will be in place in the Church and at the Cemetery.The family would like to thank you for your help and understanding at this sad time.Frances’s Requiem Mass will be streamed live on https://www.mcnmedia.tv/camera/st-michaels-church-portarlingtonFrank CroninPark Upper, Stradbally, LaoisCronin Frank, Park Upper, Stradbally, Co.Laois. Passed away on 13th July 2020 surrounded by his loving wife & family. Sadly missed & fondly remembered by his devoted wife Freida, daughters Liz & Emma. Sons Paul & Garry, sister Mary, his adored 8 grandchildren, daughter-in-law Angie, sons-in-law Garry & John, sisters-in-law, brother-in-law, nieces, nephews, extended family & a large circle of friends.Reposing at his home from 4pm on Tuesday (14th Juy) with rosary at 8pm. Requiem Mass on Wednesday (15th July) at 2:30pm in The Sacred Heart Church, Stradbally, interment to follow in Oakvale Cemetery.Following current govenment advice regarding public gatherings the funeral will be restricted to 150 people in the church. Frank’s family wish to thank everyone for their understanding at this sad time.Family flowers only, donations, if desired, to ‘The Irish Cancer Society’.Joe DunneMorette, Emo, Laois/Ballybrittas, LaoisFormerly The Old Pound, Ballybrittas County Laois. Peacefully.Deeply regretted by his loving wife Peggy, brothers Jimmy and Michael, nieces, nephews, extended family and friends.Reposing at the O’Neill’s residence Kilbracken, Ballybrittas on Tuesday from 4pm with Rosary at 8pm. Removal on Wednesday (travelling via Morette) arriving St Paul’s Church, Emo for Requiem Mass at 2pm. Funeral afterwards to the New Cemetery, Emo.Due to the Covid 19 Directive there will be Social Distancing in place in the house, in the Church and at the Cemetery.SEE ALSO – Deaths in Laois – Thursday, July 16, 2020 Electric Picnic center_img Home Deaths Deaths in Laois – Friday, July 17, 2020 Deaths Deaths in Laois – Friday, July 17, 2020 RELATED ARTICLESMORE FROM AUTHOR Facebook Facebook WhatsApp Previous articleAlmost €3,000 raised as Laois soccer club set to embark on 24 hour marathon penalty shoot-outNext articleTough task for Laois camogie as new draw made for All Ireland championship LaoisToday Reporter News Electric Picnic organisers release statement following confirmation of new festival datelast_img read more

Des bombes en poudre de piment

first_img RELATED ARTICLESMORE FROM AUTHOR Il a été transmis récemment que des femmesnord coréennes se déplacent avec des bombes lacrymogènes pour leur autodéfense.Ce sont en fait des « bombes de poudre de piment » qui leur servent àse défendre des éventuels vols et abus sexuels.Une source de la province du Hamgyeong duNord a transmi le 28 avril à Daily NK : « Des femmes des villes deCheongjin, Hamheung et Pyeongseong se déplacent avec des « bombes de poudrepiment » sur elles pour leur protection personnelle. Elles sont faitesmaison, sans chimie, et consistent en fait en un petit sac plastique de poudrede piment qu’elles peuvent saisir rapidement ».Selon la source, ce sont surtout lesvoyageuses et les femmes qui font de la vente en gros pour le marché et doiventse déplacer pour acheter des produits régionaux qui ont recours à cettepratique d’autodéfense. Comme elles se déplacent avec une quantité d’argentimportante sur elles, elles deviennent les cibles des voleurs. La solution estrapide et efficace, elle leur redonne confiance en elles pour leur activité.La source ajoute : « Au marché de Hwesangdans la ville de HamHeung, un homme qui avait volé un rasoir coûteux a été directementattrapé grâce à cela. Le propriétaire s’est écrié« Attrapez-le ! » en désignant le voleur qui s’enfuyait. Ce sontles marchands aux alentours qui, tous ensemble, se sont dirigés vers le voleurpour lui lancer la poudre au visage ».Cependant, la source explique :« Les « bombes de poudre de piment » permettent d’attraper lesvoleurs, mais elles ne sont utilisées à mauvais escient. Il y a tout demême une partie des jeunes femmes qui les utilise contre des hommes innocents. Ily a quelques jours, près du marché de Sunam, une mère d’une trentaine d’annéeshabitant à Chongjin a envoyé une « bombe de poudre de piment » sur unjeune homme à bicyclette dans une ruelle. Alors qu’il ne pouvait plus ouvrirles yeux, elle est partie avec le vélo. La coupable a expliqué plus tard qu’elleavait volé le vélo pour pouvoir célébrer l’anniversaire de son enfant avec l’argentde la revente ».Pour conclure, la source a ajouté : « Leshabitants réagissent en disant « les temps sont tellement durs que lesgens font n’importe quoi. C’est comme si quelqu’un allait nous couper le nezaussitôt que nous fermons les yeux ». Tandis que les personnes âgéescritiquent indirectement les autorités nord-coréennes en disant que ” lasociété actuelle doit prendre ses responsabilités pour ces crimes ” ». North Korea tries to accelerate building of walls and fences along border with China News SHARE Des bombes en poudre de piment AvatarChoi Song Min Entire border patrol unit in North Hamgyong Province placed into quarantine following “paratyphoid” outbreak center_img Facebook Twitter There are signs that North Korea is running into serious difficulties with its corn harvest By Choi Song Min – 2015.05.08 4:29pm News News News last_img read more

Lack of safety regulations and harsh winter leads to frequent carbon…

first_imgNewsEconomy By Daily NK – 2018.01.11 4:32pm AvatarDaily NKQuestions or comments about this article? Contact us at [email protected] RELATED ARTICLESMORE FROM AUTHOR Facebook Twitter A source in the area informed Daily NK on January 9 of an incident where “three female police officers (age 22, 25, and 28) in Taegwan County died of carbon monoxide poisoning after burning coal every day to warm up.” News In response to the problem, authorities have in the past directed local People’s Unit leaders to organize inspection teams to visit each house and order people to open doors and windows, to improve the air quality in homes.  Temperatures have plummeted in North Korea, and North Pyongan Province has reportedly been at the center of a carbon monoxide poisoning epidemic as a result of lax regulations on coal heating in private homes. The problem is that it is not very feasible, the source explained, to expect such inspection teams to be formed when locals are all busy working with other activities. Daily NK has also received a report of similar poisoning incidents from another source in Sinuiju. North Korea Market Price Update: June 8, 2021 (Rice and USD Exchange Rate Only) Meanwhile, North Korea has not shown signs of adopting major policy changes or city-level directives to address the issue. Administrative paralysis and negligence on the part of the authorities means that people are expected to perform their own repairs, leading to a widening of the income gap.center_img In addition to failing to address such incidents, medical facilities across the country are also lacking proper supplies and equipment to treat patients suffering from carbon monoxide poisoning. It is likely that the current state of affairs will continue until the North Korean authorities institute a major policy change and enforce new safety regulations.  “Most people are calling it a tragedy that such young people lost their lives, but there has also been a swirl of rumors that someone intentionally used poison gas on the group, perhaps as revenge for something,” he continued.  SHARE News A photo taken in 2013 showing chimney stacks on private homes in Musan, North Hamgyong Province. Image: Daily NK Lack of safety regulations and harsh winter leads to frequent carbon monoxide deaths in North Korea US dollar and Chinese reminbi plummet against North Korean won once again News It is common for North Koreans to burn coal briquettes to heat their homes in winter – a method which produces lethal fumes that must be properly dispersed with ventilation to prevent prolonged exposure by the home’s inhabitants.  The source reported that “around 10 people died from carbon monoxide poisoning on December 29 in Sinuiju, bringing the average in the area to about 7 deaths from such poisonings per day.”  Proposal to shift “general markets” to “specialized markets” finds little support among N. Korean leaderslast_img read more

Canadian Financials & Utilities Split Corp. to redeem shares

The redemption price payable by the fund for a Class A share on that date will be equal to the greater of the NAV per unit on that date minus the sum of $10.00 plus any accrued and unpaid distributions on the preferred shares, and nil. One unit means one preferred share and one Class A share. As at Dec. 31, 2011, the NAV per unit of the fund was estimated to be $15.33, which equates to $5.33 per Class A share and $10.00 per preferred share. The fund’s preferred shares and Class A shares are listed on the TSX under the symbols CFS.PR.A and CFS, respectively. Facebook LinkedIn Twitter Digital Consumer Dividend Fund files IPO Keywords Closed-end fundsCompanies Connor Clark & Lunn Financial Group Ltd., Clark & Lunn Financial Group IE Staff Faircourt migrates two closed-end funds to NEO Connor, Clark & Lunn Capital Markets Inc. says Canadian Financials & Utilities Split Corp. will redeem its preferred shares and Class A shares as scheduled on January 31. The redemption price for a preferred share will be equal to the lesser of $10.00 plus any accrued and unpaid distributions in respect of the preferred shares, and the NAV of the fund on that date divided by the number of preferred shares then outstanding. Related news Share this article and your comments with peers on social media Europe Blue-Chip Dividend & Growth Fund confirms termination date read more

Canadians need help planning their retirement years

first_img Keywords Retirement Survey finds Canadians aren’t sure how much they’ll need for retirement Although an increasing number of Canadians are saving for retirement, most are still stressed about their post-employment savings and can use some assistance in developing a realistic idea of what their expenses will be during these years, according to the results of a study that Toronto-based Franklin Templeton Investments Corp. released on Monday. Specifically, the firm’s 2016 Retirement Income Strategies and Expectations survey found that 70% of Canadian pre-retirees are saving for retirement, an increase from 63% in 2015 and 60% in 2014. This rising trend is in contrast to the firm’s U.S. research, which found that 59% of pre-retirees in the U.S. have begun to save for retirement, down from 61% in 2015 and 65% in 2014. Earnings surge for Great-West Lifeco in Q4 Tessie Sanci Related news Snowbirds win legal battle to reinstate out-of-province medical coverage Share this article and your comments with peers on social media The research notes that Canadian pre-retirees who work with financial advisors are likely to make retirement planning a priority, as 91% who work with a financial professional have started to save for retirement compared with 52% of Canadians who have never worked with an advisor but are still saving for retirement. Another factor that may be contributing to Canadians’ willingness to save for retirement is their increased use of workplace savings programs. Approximately one-quarter (26%) of Canadians are saving for retirement by taking advantage of salary deduction programs, says Duane Green, managing director in Canada for Franklin Templeton, in a statement. This represents an increase from the 20% of pre-retiree Canadians who stated this to be the case in 2014. “However, despite this positive savings trend in Canada, we tend to see some recurring anxieties about retirement, both from our annual survey and anecdotally in our ongoing retirement discussions with individual Canadians,” Green adds. In fact, almost three-quarters (72%) of Canadians experience varying levels of stress when thinking about their retirement savings and investments. Among the 9% who report significant stress and anxiety, 76% don’t work with an advisor. Close to one-fifth (18%) report experiencing moderate stress and anxiety regarding their retirement investments, and 65% of those individuals do not work with an advisor. “Engaging professional investment advice can help alleviate some of the stress and uncertainty surrounding the prospect of retirement,” says Matthew Williams, head of defined contribution and retirement at Franklin Templeton, in the statement. “Creating a retirement plan can help Canadians gain confidence in their preparations for whatever type of retirement they envision — whether that is working part-time, volunteering or travelling,” he continues. See also: Realities of Retirement: Four tips for clients It seems Canadians can also use some assistance in preparing a realistic retirement budget. More than two-thirds (69%) of Canadian pre-retirees believe they will spend less in retirement, yet 43% of retirees say their expenses have increased since beginning their retirement. Advisors can play a part in helping Canadians formulate and implement a retirement plan that includes a budget, notes Williams. The results from this study come from an online survey 2,006 adult Canadians and 2,019 adult Americans. Orc International’s Caravan Omnibus Surveys conducted the surveys in Canada from Jan 4-18 on behalf of Franklin Templeton. Facebook LinkedIn Twitterlast_img read more

  • Recent Posts

  • Recent Comments

    • Archives

    • Categories

    • Meta

    • Tags